Get the Stockscreener App
28.70
3.37%
-1.00
After Hours:
28.72
0.02
+0.07%
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $28.70, with a volume of 6.79M.
It is down -3.37% in the last 24 hours and down -8.60% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$29.70
Open:
$29.26
24h Volume:
6.79M
Relative Volume:
1.60
Market Cap:
$16.28B
Revenue:
$11.89B
Net Income/Loss:
$-560.00M
P/E Ratio:
-26.09
EPS:
-1.1
Net Cash Flow:
$191.00M
1W Performance:
-7.45%
1M Performance:
-8.60%
6M Performance:
-2.45%
1Y Performance:
-18.51%
1-Day Range:
$28.50
$29.52
1-Week Range:
$28.50
$31.15
52-Week Range:
$26.25
$40.49
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
28.70 | 16.28B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
512.06 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.97 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.48 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
254.40 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
227.18 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
TD Private Client Wealth LLC Buys 8,393 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
ARGA Investment Management LP Grows Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Evercore ISI Cuts Baxter International (NYSE:BAX) Price Target to $42.00 - MarketBeat
Baxter International (BAX) Receives a Hold from Wells Fargo - The Globe and Mail
Transformed Baxter, in search of stability after changes, turns to outsider CEO - Crain's Chicago Business
Bank of New York Mellon Corp Decreases Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International looking to bounce back - MarketScreener
Non-PVC IV Bags Market Is Booming So Rapidly 2025-2032 -Baxter - openPR.com
Baxter International's New Leadership: Can Andrew Hider Steer the Medtech Giant to Sustainable Growth? - AInvest
Baxter International taps Andrew Hider as CEO - Reuters
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter names Andrew Hider as next CEO - Medical Economics
Baxter turns to an automation company for its new CEO - MassDevice
ATS Corporation stock falls as CEO Hider departs for Baxter International - Investing.com
Baxter names a new CEO - Crain's Chicago Business
BofA Securities reiterates Neutral rating on Baxter International stock - Investing.com
Baxter International's New Leadership: Can Andrew Hider Replicate ATS's Turnaround in MedTech? - AInvest
Baxter International Appoints Andrew Hider as New CEO - TipRanks
Baxter names Andrew Hider as new CEO, effective September - Investing.com
Baxter Appoints Andrew Hider Chief Executive Officer - Business Wire
Baxter International Inc. (NYSE:BAX) Shares Bought by GAMMA Investing LLC - MarketBeat
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World - Business Wire
Construction begins on permanent bridge at Baxter Healthcare in Marion months after Helene - WCNC
UBS Affirms Neutral Rating on Baxter International (BAX) - MSN
BAXTER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Baxter International In - The Globe and Mail
Tobam Lowers Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Cut to Hold at Wall Street Zen - MarketBeat
Baxter International Inc. (NYSE:BAX) Shares Purchased by SG Americas Securities LLC - MarketBeat
Baxter International Inc. (NYSE:BAX) Shares Bought by Handelsbanken Fonder AB - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Bard Financial Services Inc. Acquires Shares of 28,090 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter Resumes Production of Peritoneal Dialysis Solutions - Docwire News
Stock Traders Buy Large Volume of Baxter International Call Options (NYSE:BAX) - MarketBeat
Baxter International (BAX) Announces Amended Credit Agreements - GuruFocus
José Almeida: 100 Most Influential People in Healthcare 2024 - Modern Healthcare
Baxter secures $2.2 billion credit agreement By Investing.com - Investing.com South Africa
Baxter International Amends Credit and Loan Agreements - TipRanks
Baxter International Enters Amended And Restated Five-Year Credit AgreementSEC Filing - MarketScreener
Baxter stock holds Neutral rating at UBS amid CEO transition questions - Investing.com
Transcript : Baxter International Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener
GAMMA Investing LLC Has $13.27 Million Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com
Baxter International To Present At Goldman Sachs Global Conference; Webcast At 10:40 AM ET - Nasdaq
Baxter recalls Novum pump linked to 1 serious injury - MedTech Dive
Baxter issues serious correction for large-volume infusion pump - MassDevice
Baxter International Inc. (NYSE:BAX) Sees Large Decrease in Short Interest - MarketBeat
Rhumbline Advisers Buys 99,846 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Baxter International Inc. (BAX) - ACCESS Newswire
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):